Omada Health (OMDA) CFO’s 10b5-1 exercise-and-sale and corrected holdings
Rhea-AI Filing Summary
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an exercise-and-sale transaction and corrected prior share totals. On June 22, 2026, he sold 17,950 shares of common stock in an open-market transaction at a weighted average price of $18.1278 per share under a Rule 10b5-1 trading plan adopted on March 14, 2026.
On the same date, he exercised stock options to acquire 11,111 shares at an exercise price of $7.68 per share and 6,839 shares at an exercise price of $8.01 per share. Following these transactions, he directly holds 187,209 shares of common stock.
The amendment states the original Form 4 omitted the exercise transactions, which caused the previously reported amount of securities beneficially owned after the sales to be understated. This Form 4/A restates the filing to include the exercises and adjusts the post-transaction ownership figures accordingly.
Positive
- None.
Negative
- None.
Insights
CFO executed routine option exercises paired with a planned sale and corrected prior share counts.
The filing shows Omada Health CFO Steven L. Cook exercised stock options for 17,950 shares of common stock at exercise prices of $7.68 and $8.01, then sold 17,950 shares at a weighted average price of $18.1278. This is a classic same-day exercise-and-sale pattern.
After these transactions, he directly owns 187,209 common shares, indicating he retains a substantial equity position. A footnote explains the original Form 4 omitted the exercises, understating his beneficial ownership, and this amendment corrects Box 5 in Table I.
The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026, suggesting the timing was pre-planned rather than discretionary. Overall, the activity appears routine and administrative, with limited implications beyond clarifying his true post-transaction holdings.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 6,839 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 11,111 | $0.00 | -- |
| Exercise | Common Stock | 6,839 | $8.01 | $55K |
| Exercise | Common Stock | 11,111 | $7.68 | $85K |
| Sale | Common Stock | 17,950 | $18.1278 | $325K |
Footnotes (1)
- This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. This transaction was executed in multiple trades at prices ranging from $18.00 to $18.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.